Low-kilovolt x-ray intraoperative radiotherapy for pT3 locally advanced colon cancer: a single-institution retrospective analysis.
Intraoperative radiotherapy
Locally advanced colon cancer
Low-kV x-ray
pT3 colon cancer
Journal
World journal of surgical oncology
ISSN: 1477-7819
Titre abrégé: World J Surg Oncol
Pays: England
ID NLM: 101170544
Informations de publication
Date de publication:
17 Jun 2020
17 Jun 2020
Historique:
received:
03
03
2020
accepted:
02
06
2020
entrez:
20
6
2020
pubmed:
20
6
2020
medline:
15
4
2021
Statut:
epublish
Résumé
Patients with locally advanced colon cancer (LACC) treated with surgery had a high risk of local recurrence. The outcomes can vary significantly among patients with pT3 disease. This study was undertaken to assess whether low-kilovolt (kV) x-ray intraoperative radiotherapy (IORT) can achieve promising results compared with electron beam IORT (IOERT) and whether specific subgroups of patients with pT3 colon cancer may benefit from low-kV x-ray IORT. We retrospectively reviewed 44 patients with pT3 LACC treated with low-kV x-ray IORT. Clinicopathologic characteristics were analyzed to identify patients that could potentially benefit from low-kV x-ray IORT. The Kaplan-Meier survival analysis was used to assess overall survival (OS) and progression-free survival (PFS). Correlation analysis was used to discover the association of multiple factors to the results of treatment represented by the values of OS and PFS. The median follow-up of patients was 20.5 months (range, 6.1-38.8 months). At the time of analysis, 38 (86%) were alive and 6 (14%) had died of their disease. The 3-year Kaplan-Meier of PFS and OS for the entire cohort was 82.8% and 82.1%, respectively. At median follow-up, no in-field failure within the low-kV x-ray IORT field had occurred. Locoregional and distant failure had occurred in 2 (5%) patients each. The rate of perioperative 30-day mortality was 0%, and the morbidity rate was 11%. Five patients experienced 7 complications, including 4 early complications (30 days) and three late complications (> 30 days) leading early and late morbidity rates of 9% and 7%, respectively. Patients with LACC who had undergone an additional low-kV x-ray IORT can achieve encouraging locoregional control, PFS, OS, and distant control without an increase in short-term or long-term complications. Low-kV x-ray IORT can be considered as part of management in pT3 LACC.
Sections du résumé
BACKGROUND
BACKGROUND
Patients with locally advanced colon cancer (LACC) treated with surgery had a high risk of local recurrence. The outcomes can vary significantly among patients with pT3 disease. This study was undertaken to assess whether low-kilovolt (kV) x-ray intraoperative radiotherapy (IORT) can achieve promising results compared with electron beam IORT (IOERT) and whether specific subgroups of patients with pT3 colon cancer may benefit from low-kV x-ray IORT.
METHODS
METHODS
We retrospectively reviewed 44 patients with pT3 LACC treated with low-kV x-ray IORT. Clinicopathologic characteristics were analyzed to identify patients that could potentially benefit from low-kV x-ray IORT. The Kaplan-Meier survival analysis was used to assess overall survival (OS) and progression-free survival (PFS). Correlation analysis was used to discover the association of multiple factors to the results of treatment represented by the values of OS and PFS.
RESULTS
RESULTS
The median follow-up of patients was 20.5 months (range, 6.1-38.8 months). At the time of analysis, 38 (86%) were alive and 6 (14%) had died of their disease. The 3-year Kaplan-Meier of PFS and OS for the entire cohort was 82.8% and 82.1%, respectively. At median follow-up, no in-field failure within the low-kV x-ray IORT field had occurred. Locoregional and distant failure had occurred in 2 (5%) patients each. The rate of perioperative 30-day mortality was 0%, and the morbidity rate was 11%. Five patients experienced 7 complications, including 4 early complications (30 days) and three late complications (> 30 days) leading early and late morbidity rates of 9% and 7%, respectively.
CONCLUSION
CONCLUSIONS
Patients with LACC who had undergone an additional low-kV x-ray IORT can achieve encouraging locoregional control, PFS, OS, and distant control without an increase in short-term or long-term complications. Low-kV x-ray IORT can be considered as part of management in pT3 LACC.
Identifiants
pubmed: 32552838
doi: 10.1186/s12957-020-01903-x
pii: 10.1186/s12957-020-01903-x
pmc: PMC7301558
doi:
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
132Subventions
Organisme : The First Hospital of Qiqihar City
ID : R073290127
Organisme : BLRD VA
ID : I01 BX000671
Pays : United States
Références
Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):504-11
pubmed: 17560736
Dis Colon Rectum. 2012 Jun;55(6):695-702
pubmed: 22595850
Am J Surg. 2017 Mar;213(3):586-589
pubmed: 28160966
Brachytherapy. 2019 May - Jun;18(3):292-298
pubmed: 30497939
Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):106-12
pubmed: 14697427
J Clin Oncol. 2007 Mar 10;25(8):971-7
pubmed: 17350946
Am J Surg. 2013 Nov;206(5):758-63
pubmed: 23835209
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Radiat Oncol. 2020 Jan 10;15(1):11
pubmed: 31924250
Int J Radiat Oncol Biol Phys. 1997 Jan 1;37(1):51-8
pubmed: 9054876
Dis Colon Rectum. 2018 Sep;61(9):1016-1025
pubmed: 30086050
Dis Colon Rectum. 1994 Jul;37(7):635-42
pubmed: 8026228
Cancer Lett. 2011 Jul 28;306(2):121-33
pubmed: 21414718
Int J Radiat Oncol Biol Phys. 1997 Jul 1;38(4):777-83
pubmed: 9240646
Ann Surg Oncol. 2017 Apr;24(4):1093-1099
pubmed: 27812826
Ann Surg Oncol. 2015 Jul;22(7):2168-78
pubmed: 25631062
Radiat Oncol. 2012 Jul 20;7:110
pubmed: 22817880
J Surg Oncol. 2019 Dec;120(8):1427-1435
pubmed: 31729037
Brachytherapy. 2019 May - Jun;18(3):242-257
pubmed: 31084904
Radiat Oncol. 2017 Jan 11;12(1):11
pubmed: 28077144
Dis Colon Rectum. 2015 Aug;58(8):743-52
pubmed: 26163953
Ann Surg. 2008 Oct;248(4):592-8
pubmed: 18936572
Ann Surg. 1984 Dec;200(6):685-90
pubmed: 6508395
Pathol Biol (Paris). 1992 Nov;39(9):884-5
pubmed: 1538921
Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):219-26
pubmed: 10924992